2017 Lecture Series:

December 14, 2017 Victor Montori, Mayo Clinic
"Patient Understanding of Medical Products: Shared-Decision Making and FDA Policy"
November 3, 2017
Harlan Krumholz, Yale University School of Medicine
"HuGO: A Novel Smartphone-Based Mobile Health Platform"
October 3, 2017 Kannan Rangaramanujam, JHU CERSI
"Systemic, Targeted Nanotherapies for Neurological Disorders"
September 14, 2017
Laura Esserman, UCSF-Stanford CERSI
"Breast Cancer Oncology: One Source Project"
June 26, 2017 David Smith, University of Maryland (M-CERSI)
"Role and Revevance of Proton-Coupled Oligopeptide Transporters in the Brain"
June 6, 2017
Kathryn Sandbert, Georgetown University CERSI
"Sex Differences and Vascular Disease: Presentation, Diagnostics and Treatment" 
May 11, 2017 Steve Goodman, UCSF-Stanford CERSI
"Reproducibility in Medicine and Science"
April 13, 2017
Monica McArthur, University of Maryland CERSI (M-CERSI)
March 14, 2017 Peter Doshi, University of Maryland CERSI (M-CERSI)
“Ensuring Accuracy of Clinical Trial Publications”
February 9, 2017
Nitish Thakor, Ph.D., Johns Hopkins University
"Neuroprosthetics and Brain Machine Interface: Innovation to Implementation"
January 19, 2017 Ray Dorsey, M.D., MBA, University of Rochester Medical Center
"Telemedicine: The Future of Clinical Trials"

2016 Lecture Series:

December 8, 2016 Joe Wu, UCSF-Stanford CERSI
“Stem Cells Biology”
November 30, 2016
Chris Re, UCSF-Stanford CERSI
"Deep Dive Knowledge Management”
October 26, 2016 Steve Quake, UCSF-Stanford CERSI
“Genomic Based Diagnostics”
September 20, 2016(406)
Louis Weiner, MD, Georgetown CERSI
"Antibody-Targeted Cancer Immunotherapy”
June 21, 2016 (190) Evan Mayo-Wilson JHU CERSI
“Measuring Harms that Matter to Patients in Clinical Trials's”
May 17, 2016(165)
Michael Fischbach UCSF-Stanford CERSI
“Gut Microbiome and Health Diseases”
April 19, 2016 (175) John Bridges JHU CERSI
“An Introduction to the Art and Science of Measuring Patient and Caregiver Preferences”
March 15, 2016 (87)
Esteban G. Burchard, MD, MPH, Professor, Department of Bioengineering & Therapeutic Sciences and Medicine, University of California, San Francisco
“Making Precision Medicine Socially Precise”
February 16, 2016 (164) G. Elliott Cook, PharmD, BCPS, Chief Pharmacist, Provider Resources, Inc.
“Measuring the Impact of FDA Communication Alerts and Re-Alerts”
January 19, 2016 (291)
Michael Stoto, PhD, Professor, Health Systems Administration and Population Health, University of Georgetown 
“Drug Safety Meta-Analysis: Promises and Pitfalls”


2015 Lecture Series:

November 17, 2015 (86) Dr. Jose Jalife, MD, Director, Center for Arrhythmia Research, University of Michigan
“Human Heart in the Dish: Novel In Vitro Cardiotoxicity Testing Platform”
October 20, 2015 (26) Myong-Hee Sung, PhD, Staff Scientist, Center for Cancer Research, National Cancer Institute
"Systems Biology of Cell Signaling and Drug Responses through Modeling and Microscopy"
April 14, 2015  (186) Donald Berry, PhD, University of Texas, MD Anderson Cancer Center
“Clinical Trial Design: Bayesian Approaches and Simulations”
December 9, 2014  (38) Rose Blackburne, M.D., MBA, Global Head, Medical Delivery Solutions, Interim North America Head
"Oncology Therapeutic Strategy & Medical Delivery Therapeutic Delivery Unit"


2014 Lecture Series:

November 18, 2014 (70) John Michael Sauer, PhD, Executive Director, Predictive Safety Testing Consortium (PSTC) Critical Path Institute
“Building a Translational Safety Strategy: An Overview of Nonclinical and Clinical Biomarker Qualification Efforts in the Predictive Safety Testing Consortium (PSTC)” 
November 12, 2014 (67) David Pisetsky, M.D., PhD, Executive Director, Predictive Safety Testing
“The Immune Properties of Natural and Synthetic DNA”
October 15, 2014 (29) Eytan Ruppin, PhD, Professor, School of Computer Science & Sackler Faculty of Medicine
“Identifying Novel Selective Cancer Drug Targets”
September 12, 2014 (145)  Lori Herz, PhD, Lehigh University, Bethlehem PA
“Shortages of Injectable Drugs: CMC-Related Causes and Potential Solutions”
June 18, 2014 (100) Arthur Atkinson Jr., MD, M.A.C.P. Feinberg School of Medicine, Northwestern University
“Pharmacokinetic Studies in Patients with Impaired Renal Function”
May 28, 2014 (128) Ruth Day, PhD Duke University Durham, North Carolina
“Enhanced Formats for Drug Information: Effects on Attention Comprehension and Memory”
May 14, 2014 (22) Susan dosReis, PhD University of Maryland Baltimore
“Antipsychotic Treatment Patterns and Dosing in Pediatric Foster Care: Does Outpatient Treatment Conform with the Evidence-Base?”
April 7, 2014  (36) Julie Zito, University of Maryland School of Pharmacy
“Antipsychotic Use Patterns in Medicaid-insured Youth in California: Variations by Region and Race/ethnicity”
March 3, 2014 Julie Zito, University of Maryland School of Pharmacy
“Antipsychotic Use Patterns in Medicaid-insured Youth in California: Variations by Region and Race/ethnicity” 
** Postponed due to weather **
February 19, 2014 (137) Richard Kim, MD University of Western Ontario, Canada
“Clinical and Pharmacogenomic Predictors of Statin Disposition and Response” 
January 24, 2014 (32) Michael Zachariah, PhD University of Maryland Dept. of Chemistry and Biochemistry
“Characterization of Nano-biomaterials with Electrospray Differential Mobility Analysis”


2013 Lecture Series:

December 3, 2013 (54) David R. Goodlett, PhD University of Maryland School of Pharmacy
Baltimore “Novel Applications/Methods of Mass Spectrometry (MS) in Drug and Biologic R & D”
Nov. 25, 2013 (42) Gregory Payne, PhD University of Maryland Fischell Dept. of Bioengineering
Topic to be determined
Oct. 21, 2013 (141) Diane Jorkasky, M.D., F.A.C.P., CMO of Complexa Therapeutics
“A Clinician’s Journey to Enlightenment” (or how I got exposed to exposure)
July 22, 2013 (16) Don DeVoe, PhD University of Maryland Mechanical Engineering Dept.
“Microfluidic-Enabled Liposomes for Targeted Drug Delivery”
June 27, 2013 (64) Vence Bonham, J.D. National Institute of Health Education and Community
“Reducing Racial and Ethnic Health Disparities: Is Genomic Medicine the Path?"
May 3, 2013 (86) Curtis Klaassen, PhD   University of Kansas Medical Center
“New and Future Mechanisms of Hepatotoxicity”
April 10, 2013  (121) David Greenblatt, M.D.  Tufts University of Medicine and Tufts Medical Center
“Drug Interactions with Fruit Beverages and Natural Products: Mechanisms and Consequences”
March 25, 2013 Vence Bonham, J.D. National Institute of Health-Education and Community
“Reducing Racial and Ethnic Health Disparities: Is Genomic Medicine the Path?”  **Postponed due to weather**
Feb. 28, 2013 (45) Peter Sorger, PhD  Harvard Medical School
“Measuring and Modeling Oncogenic Networks and Drugs that Target Them”
Feb. 11, 2013  (74) Anjan Nan, PhD University of Baltimore Dept. of Pharmaceutical Science
“Nanotechnology and Drug Delivery”
Jan. 28, 2013  (53) Stephen Thomas, PhD  University of Maryland School of Public Health
“Accelerating 4th Generation Disparities Research to Achieve Health Equity”


2012 Lecture Series:

Dec. 10, 2012 (59) John Fisher, PhD University of Maryland Fischell Dept. of Bioengineering
“Bone Tissue Engineering with Biomaterials and Bioreactors”
Nov. 27, 2012 (57) Peggy Compton, PhD  Georgetown Univ. School of Nursing & Health Studies
“Opioid-induced Hyperalgsai”
Oct. 30, 2012 Anjan Nan, PhD  University of Baltimore Dept. of Pharmaceutical Science
“Nanotechnology and Drug Delivery”  **Postponed due to weather**
Aug. 27, 2012 (68) William Bentley, PhD University of Maryland Fischell Dept. of Bioengineering
“Biofabrication: An Assemble Paradigm for Device Construction the Facilitates Communication”
July 23, 2012  (64) Yu Chen, PhD University of Maryland Fischell Dept. of Bioengineering
“Novel OCT Imaging and Sensing Devices for Clinical Translation”
June 21, 2012  (80) Annette Stemhagen, PhD, United Bio Source Corporation
“The Role of Patient-Provider Agreements in the Context of Risk Evaluation and Mitigation Strategies with Emphasis on Opids”
April 19, 2012    (67) Vadivel Ganapathy, PhD  Georgia Health Sciences
“Inhibition of the Amino Acid Transporter SLC6A14 to Treat Cancer”
Total Attendance:

3671 Attendance;  149 CE Credits Earned